Skip to main content

Table 1 Clinical and laboratorial characteristics of patients and controls

From: Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy

 

Patients

(n = 36)

Controls

(n = 8)

p

Age

54 (48-61)

52 (45-54)

0.12

Male gender (n, %)

30 (83.3)

5 (62.5)

0.33

Cirrhosis aetiology

   

 Alcoholic (n, %)

21 (58.3)

  

 Viric (n, %)

10 (27.8)

  

 Other (n, %)

5 (13.9)

  

Child-Pugh score

5 (5-7)

  

MELD score

9 (7-11)

  

Diuretic use (n, %)

7 (19.4 %)

  

Heart rate

72 (58-78)

69 (51-72)

0.20

Mean blood pressure

98 (88-106)

100 (99-104)

0.64

Blood analysis

   

 Haemoglobin (g/dL)

13.4 (11.5-15.3)

14.4 (13.6-15.5)

0.21

 Platelet count (×109/L)

101 (76-142)

225 (182-256)

<0.001

 Creatinine (mg/dL)

0.63 (0.52-0.79)

0.74 (0.49-0.95)

0.66

 Sodium (mEq/L)

139 (137-141)

142 (140-143)

0.035

 Total bilirubin (mg/dL)

0.92 (0.61-1.30)

0.34 (0.22-0.48)

<0.001

 Albumin (g/dL)

4.1 (3.6-4.5)

4.6 (4.5-4.9)

0.005

 NT-ProBNP (pg/mL)

58 (30-140)

32 (22-53)

0.20

 CRP (mg/dL)

0.25 (0.11-0.52)

0.16 (0.06-0.38)

0.42

 INR

1.2 (1.1-1.3)

1.0 (0.9-1.1)

0.001

  1. Results are presented as median (25th–75th percentile) for quantitative variables
  2. CRP C-Reactive Protein, INR International Normalized Ratio, MELD Model for End-Stage Liver Disease, NT-proBNP N-terminal pro–B-type natriuretic peptide